Home › Funds › Ninety One UK Ltd › EW
Ninety One UK Ltd position in EW
EDWARDS LIFESCIENCES CORP · Health Care
Ninety One UK Ltd reported holding 11,943,675 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$1.03B, representing 2.27% of its reported portfolio and ranking #10 among its reported holdings. Ninety One UK Ltd has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Ninety One UK Ltd's EW position evolved
Ninety One UK Ltd first disclosed a stake in EW in Q3 2023 at 17,533 shares (US$1.2M). The position peaked in Q2 2026 at 12,337,502 shares, worth US$1.12B. Across 13 filings, Ninety One UK Ltd increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 11,943,675 shares valued at US$1.03B — a reduction of -393,827 shares quarter over quarter.. Notable position changes include a 2741% increase in Q4 2023 (shares rose 25% over the following quarter), a 1659% increase in Q3 2024 (shares rose 12% over the following quarter), a 60% increase in Q1 2026 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 17.53K | $1.21M | New |
| Q4 2023 | 498.03K | $37.97M | Add |
| Q1 2024 | 599.32K | $57.27M | Add |
| Q2 2024 | 415.76K | $38.40M | Reduce |
| Q3 2024 | 7.31M | $482.50M | Add |
| Q4 2024 | 7.18M | $531.88M | Reduce |
| Q1 2025 | 7.00M | $507.68M | Reduce |
| Q2 2025 | 6.94M | $542.74M | Reduce |
| Q3 2025 | 7.91M | $615.05M | Add |
| Q4 2025 | 7.73M | $659.40M | Reduce |
| Q1 2026 | 12.40M | $992.68M | Add |
| Q2 2026 | 12.34M | $1.12B | Hold |
| Q3 2026 | 11.94M | $1.03B | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EW and 13F data
EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 33 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Aristotle Capital Management, LLC (US$783.9M), BROWN ADVISORY INC (US$666.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M sh · $1.18B · Q2 2026
- Aristotle Capital Management, LLC 8.67M sh · $783.91M · Q2 2026
- BROWN ADVISORY INC 7.37M sh · $666.33M · Q2 2026
- Artisan Partners Limited Partnership 6.63M sh · $599.36M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 4.80M sh · $434.21M · Q2 2026
More on Ninety One UK Ltd
FAQ
How long has Ninety One UK Ltd held EW?
Ninety One UK Ltd has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Ninety One UK Ltd's current position in EW?
As of Q3 2026, Ninety One UK Ltd holds 11.94M shares of EW (EDWARDS LIFESCIENCES CORP), valued at $1.03B, representing 2.27% of its reported portfolio and ranking #10.
Has Ninety One UK Ltd been buying or selling EW?
In the latest 13F filing (Q3 2026), Ninety One UK Ltd reduced its position in EW. The position peaked in Q2 2026 at 12.34M shares.
Which other funds hold EW?
Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Aristotle Capital Management, LLC, BROWN ADVISORY INC, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.